Novartis AG ADR (NYSE:NVS) has a beta value of 0.55 and has seen 1.24 million shares traded in the recent trading session. The company, currently valued at $184.79B, closed the recent trade at $94.45 per share which meant it lost -$1.36 on the day or -1.42% during that session. The NVS stock price is -15.17% off its 52-week high price of $108.78 and 5.92% above the 52-week low of $88.86. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.62 million shares traded. The 3-month trading volume is 1.44 million shares.
Novartis AG ADR (NYSE:NVS) trade information
Sporting -1.42% in the red today, the stock has traded in the green over the last five days, when the NVS stock price touched $94.45 or saw a rise of 3.83%. Year-to-date, Novartis AG ADR shares have moved -6.46%, while the 5-day performance has seen it change 0.08%. Over the past 30 days, the shares of Novartis AG ADR (NYSE:NVS) have changed -6.83%. Short interest in the company has seen 4.21 million shares shorted with days to cover at 2.77.
Novartis AG ADR (NVS) estimates and forecasts
Figures show that Novartis AG ADR shares have underperformed across the wider relevant industry. The company’s shares have lost -3.22% over the past 6 months, with this year growth rate of 3.91%, compared to 4.00% for the industry. Other than that, the company has, however, increased its growth outlook for the 2024 fiscal year revenue. Growth estimates for the current quarter are -1.20% and -1.10% for the next quarter. Revenue growth from the last financial year stood is estimated to be 5.70%.
3 analysts offering their estimates for the company have set an average revenue estimate of $11.48 billion for the current quarter. 3 have an estimated revenue figure of $11.99 billion for the next quarter concluding in Jun 2024. Year-ago sales stood $12.64 billion and $13.62 billion respectively for this quarter and the next, and analysts expect sales will shrink by -9.20% for the current quarter and -12.00% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 5.63% over the past 5 years. Earnings growth for 2024 is a modest 9.43% while over the next 5 years, the company’s earnings are expected to increase by 6.68%.
NVS Dividends
Novartis AG ADR is expected to release its next earnings report in May this year, and investors are excited at the prospect of better dividends despite the company’s debt issue. The forward dividend is 3.78 at a share yield of 4.00%. The company’s dividend yield has gone up over the past 12 months.
Novartis AG ADR (NYSE:NVS)’s Major holders
Insiders own 0.00% of the company shares, while shares held by institutions stand at 6.93% with a share float percentage of 6.93%. Investors are also buoyed by the number of investors in a company, with Novartis AG ADR having a total of 1,376 institutions that hold shares in the company. The top two institutional holders are Dodge & Cox Inc with over 16.41 million shares worth more than $1.66 billion. As of Jun 29, 2023, Dodge & Cox Inc held 0.72% of shares outstanding.
The other major institutional holder is Primecap Management Company, with the holding of over 15.01 million shares as of Jun 29, 2023. The firm’s total holdings are worth over $1.51 billion and represent 0.66% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Dodge & Cox Stock Fund and Vanguard/Primecap Fund. As of Jun 29, 2023, the former fund manager holds about 0.52% shares in the company for having 11.82 million shares of worth $1.19 billion while later fund manager owns 9.01 million shares of worth $908.75 million as of Jun 29, 2023, which makes it owner of about 0.40% of company’s outstanding stock.
